DON'T MISS

Here we go again with the ups and downs. All major indexes opened the day with a sharp gap down, the fall continuing until the...

Investing in biotech is unlike investing in any other sector of the market. Much of the time, investors will look to take a position...

Stock News & Insights

In October last year, DBV Technologies (NASDAQ:DBVT) hit the markets with a pretty disappointing IPO, closing out at an average of around $21 per...

At the end of last week, we learned that Denmark based Novo Nordisk A/S (ADR) (NYSE:NVO) had achieved promising results in its once weekly...

With all the hype surrounding the potential biotech bubble and the flurry of IPOs we've seen over the last few weeks, it is easy...

2015 has been pretty hot year for biotech IPOs. The space as a whole has expanded close to 400% over the past five years,...

Biopharmaceutical incumbent Novartis AG (NYSE:NVS) stock has struggled of late, having had something of a bumper first half of the year, reaching May highs...
ads from sponsors

Our Featured Authors

31 POSTS0 COMMENTS
7 POSTS0 COMMENTS
2 POSTS0 COMMENTS
6 POSTS0 COMMENTS